This review summarizes recent advances in CRISPR‐based diagnostics, focusing on Cas12, Cas13, and Cas14, along with key platforms including SHERLOCK, DETECTR, and FELUDA, and discusses their integration with POC technologies such as microfluidic devices, lateral‐flow assays, and smartphone‐based detection systems.
Taru Singh, Akshat Chilkoti, A. Nagar et al.· ChemistrySelect· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.